Study of ENMD-2076 in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen
- Status
- UNKNOWN
- Phase
- PHASE2
Total Marrow Irradiation & Autologous Stem Cell Transplantation for Relapsed or Refractory Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Further Assess Safety and Effectiveness Data of the Bortezomib(Velcade)/Melphalan/Prednisone (BMP) Regimen in Previously Untreated and Transplant Ineligible Multiple Myeloma Patients
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Melphalan, Bortezomib, and Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose-Reduced Allogeneic Stem Cell Transplantation After Autologous High-Dose Chemotherapy in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE2
Dose-finding of Lenalidomide as Maintenance in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Auto-Allo Tandem Stem Cell Transplantation for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1/2 Study of Anti GM-2 Monoclonal Antibody To Treat Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
- Status
- COMPLETED
- Phase
- PHASE3
Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Romidepsin and Bortezomib for Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Comparison of Zometa Retention and Effect in Multiple Myeloma and Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Japan Phase I/II Study of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2